Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.

Iris Shiran,Eyal Heller,Shlomit Jessel,Iris Kamer,Inbal Daniel-Meshulam,Rossie Navon,Damien Urban,Amir Onn,Jair Bar

Clinical Lung Cancer（2017）

引用 6|浏览17

暂无评分

摘要

Pulmonary adenocarcinoma has a better prognosis than NFA, regarding advanced NSCLC treated with platinum-pemetrexed combination chemotherapy. This distinction should be a stratification factor in clinical trials and a prognostic factor to consider in analysis of previous trials.

查看译文

关键词

Immunohistochemistry,Non-squamous,NSCLC,Platinum-pemetrexed doublet,TTF1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要